Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer
Clinical trial NCT01533181 · COMPLETED
Trial details
- NCT number
- NCT01533181
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2014-11-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.